Advances of Osteosarcoma Models for Drug Discovery and Precision Medicine

The management of osteosarcoma (OS) patients presents a significant clinical challenge. Despite progress in conventional and targeted therapies, the survival rate of OS patients remains limited largely due to therapy resistance and the high metastatic potential of the disease. OS models that accurat...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Linyun, Wang, Yitian, Hu, Xin, Du, Guifeng, Tang, Xiaodi, Min, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10527053/
https://www.ncbi.nlm.nih.gov/pubmed/37759763
http://dx.doi.org/10.3390/biom13091362

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10527053/
https://www.ncbi.nlm.nih.gov/pubmed/37759763
http://dx.doi.org/10.3390/biom13091362

Ejemplares similares